<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>144(6)</volume><submitter>Malmgren L</submitter><pubmed_abstract>&lt;h4>Background/aims&lt;/h4>Prospective data on age-related changes in kidney function are required, especially since the current Kidney Disease Improving Global Outcomes (KDIGO) definition has been suggested to classify a large number of elderly people with CKD.&lt;h4>Objective&lt;/h4>This study, a complement to our previous Cr-based study in the same cohort, is aimed at evaluating cystatin C (cysC)-based changes in kidney function during aging in older women and analyzing the association between CKD and mortality through 10 years of follow-up.&lt;h4>Methods&lt;/h4>cysC was available in 981 women from the Osteoporosis Prospective Risk Assessment (OPRA) cohort, all aged 75 years on entry. Reinvestigations were made after 5 (n = 685) and 10 years (n = 365). Kidney function was estimated (estimated glomerul</pubmed_abstract><journal>Nephron</journal><pagination>290-298</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7384338</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Longitudinal Changes in Kidney Function Estimated from Cystatin C and Its Association with Mortality in Elderly Women.</pubmed_title><pmcid>PMC7384338</pmcid><pubmed_authors>Malmgren L</pubmed_authors><pubmed_authors>McGuigan FE</pubmed_authors><pubmed_authors>Christensson A</pubmed_authors><pubmed_authors>Akesson KE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Longitudinal Changes in Kidney Function Estimated from Cystatin C and Its Association with Mortality in Elderly Women.</name><description>&lt;h4>Background/aims&lt;/h4>Prospective data on age-related changes in kidney function are required, especially since the current Kidney Disease Improving Global Outcomes (KDIGO) definition has been suggested to classify a large number of elderly people with CKD.&lt;h4>Objective&lt;/h4>This study, a complement to our previous Cr-based study in the same cohort, is aimed at evaluating cystatin C (cysC)-based changes in kidney function during aging in older women and analyzing the association between CKD and mortality through 10 years of follow-up.&lt;h4>Methods&lt;/h4>cysC was available in 981 women from the Osteoporosis Prospective Risk Assessment (OPRA) cohort, all aged 75 years on entry. Reinvestigations were made after 5 (n = 685) and 10 years (n = 365). Kidney function was estimated (estimated glomerul</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-04-19T23:04:48.648Z</modification><creation>2025-04-19T23:04:48.648Z</creation></dates><accession>S-EPMC7384338</accession><cross_references><pubmed>32392561</pubmed><doi>10.1159/000507256</doi></cross_references></HashMap>